BTLA and melanoma: Previous studies have identified that BTLA can suppress the proliferation of Vδ2 T cells (39), while blocking the PD-1 and CTLA-4 pathways can restore T cell function and improve survival in melanoma, colon carcinoma, and ovarian carcinoma (40, 41).